Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X:
“MARBLE study: single arm phase 2 study of carbo+ pacli+ atezo in thymic cancer (n=48)
ORR 56.3%, DCR 97.2%
1 year PFS 43.3%, 1 Year OS 91.3%
all patients had any grade IRAE, 66.7% grade 3.”
